HR3951

This bill, HR3951, directly amends Section 504 of the Veterans' Benefits Improvements Act of 1996 and Section 2002 of the Johnny Isakson and David P. Roe, M.D. Veterans Health Care and Benefits Improvement Act of 2020. It expands the types of healthcare professionals eligible to perform VA disability examinations under contract, moving beyond physicians, physician assistants, nurse practitioners, audiologists, and psychologists to include any person eligible for a Veterans Health Administration position under 38 U.S.C. 7402(b) with a current, unrestricted license. Crucially, it extends the sunset date for this program from five years post-enactment of the 2020 Act to January 5, 2031. This legislative action immediately secures and expands a significant revenue channel for companies providing these outsourced services to the VA. The money trail for this bill flows directly into the coffers of contract medical examination providers. The VA contracts these services to third-party companies to manage the volume and specialized nature of disability claims. By expanding the pool of eligible healthcare professionals and extending the program's duration, the VA increases its capacity to process claims, which in turn increases the demand for contracted services. Companies like Logistics Health Incorporated (LHI), a subsidiary of Optum, which is part of UnitedHealth Group ($UNH), and QTC Management, a subsidiary of Leidos ($LDOS), are primary beneficiaries. These companies receive direct payments from the VA for each examination performed, and this bill ensures those contracts continue and potentially grow. Historically, similar expansions of VA services or extensions of programs have led to increased contract opportunities for healthcare providers. While specific stock movements tied solely to VA contract extensions are not always isolated, the passage of the Johnny Isakson and David P. Roe, M.D. Veterans Health Care and Benefits Improvement Act of 2020 (Public Law 116-315) in December 2020, which initially established the temporary licensure program, solidified the market for these contractors. Following this, companies like Leidos ($LDOS) and UnitedHealth Group ($UNH) saw consistent revenue from their respective subsidiaries' VA contracts. For example, Leidos's QTC Management has been a long-standing VA contractor, and extensions of such programs directly contribute to their services segment revenue. The current bill provides a clear, long-term revenue visibility for these companies. Specific winners include UnitedHealth Group ($UNH) through its Optum subsidiary's LHI, Leidos ($LDOS) through its QTC Management subsidiary, and other medical examination providers like Concentra, a subsidiary of Select Medical Holdings Corporation ($SEM), and possibly smaller, regional providers. These companies gain from the extended program duration and the expanded scope of eligible examiners, which increases their operational flexibility and potential for contract fulfillment. There are no direct losers identified by this bill; it expands opportunities rather than restricting them. This bill is currently in the House and has been referred to the Committee on Veterans' Affairs. Given the bipartisan sponsorship and the nature of improving veteran access to benefits, it has a high likelihood of passing. The next step is committee review, followed by a potential House vote. If passed by the House, it moves to the Senate. The effective date of the extension is January 5, 2031, providing a clear long-term horizon for contract planning.